Skip to main content

Advertisement

SpringerLink
Log in

Low Molecular Weight Heparin in Obstetric Care: A Review of the Literature

  • Review
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Low molecular weight heparins (LMWHs) are widely used during pregnancy since several randomized controlled trials have demonstrated their important role in preventing not only thromboembolic disease but also pregnancy complications associated with thrombophilia: recurrent pregnancy loss (RPL), fetal growth restriction (FGR), preeclampsia (PE), abruptio placentae and intrauterine fetal death (IUFD). LMWHs have revealed their effectiveness in reducing the recurrence of negative obstetrics events even in patients without known trombophilias, despite the mechanisms whereby LMWHs operate remain still unclear. However, in order to confirm the suggested benefits, adequately powered and properly controlled trials are needed in this area. Such trials are currently underway and their results will be important to inform evidence-based practice in this area. In our review we report the results of the most relevant trials performed to assess the efficacy of LMWHs in preventing pregnancy complications associated or not with maternal thrombophilia. This review was conducted based on a MEDLINE search for relevant articles between January 2000 and August 2010 and using the following search terms: heparin, low molecular weight heparin, thrombophilia, pregnancy complications, preeclampsia, recurrent pregnancy loss, abruptio placentae, fetal growth restriction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Greer IA. Antithrombotic therapy for recurrent miscarriage. N Engl J Med. 2010;362(17):1630–1631.

    Article  CAS  PubMed  Google Scholar 

  2. Pabinger I. Thrombophilia and its impact on pregnancy. Thromb Res. 2009;123(suppl 3):S16–S21.

    Article  CAS  PubMed  Google Scholar 

  3. Kujovich JL. Thrombophilia and pregnancy complications. Am J Obstet Gynecol. 2004;191(2):412–424.

    Article  PubMed  Google Scholar 

  4. Lussana F, Dentali F, Abbate R, et al. Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res. 2009;124(5):e19–e25.

    Article  CAS  PubMed  Google Scholar 

  5. Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. 2008;6(4):632–637.

    Article  CAS  PubMed  Google Scholar 

  6. Gerhardt A, Scharf RE, Beckmann MW, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med. 2000;342(6):374–380.

    Article  CAS  PubMed  Google Scholar 

  7. Middeldorp S. Thrombophilia and pregnancy complications: cause or association? J Thromb Haemost. 2007;5(suppl 1):276–582.

    Article  CAS  PubMed  Google Scholar 

  8. Martinelli I, Legnani C, Bucciarelli P, Grandone E, De Stefano V, Mannucci PM. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost. 2001;86(3):800–803.

    CAS  PubMed  Google Scholar 

  9. Preston FE, Rosendaal FR, Walker ID, et al. EPCOT study: increased fetal loss in women with heritable thrombophilia. Lancet. 1996;348(9032):913–916.

    Article  CAS  PubMed  Google Scholar 

  10. Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 1999;340(1):9–13.

    Article  CAS  PubMed  Google Scholar 

  11. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophila and adverse pregnancy outcome) A systematic review. Eur J Obstet Gynecol Reprod Biol. 2002;101(1):6–14.

    Article  PubMed  Google Scholar 

  12. Dudding TE, Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden gentype: a meta-analysis. Thromb Haemost. 2004;91(4):700–711.

    Article  CAS  PubMed  Google Scholar 

  13. Mello G, Parretti E, Marozio L, et al. Thrombophilia is significantly associated with severe preeclampsia. Results of a large-scale, case-controlled study. Hypertension. 2005;46(6):1270–1274.

    Article  CAS  PubMed  Google Scholar 

  14. Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2005;132(2):171–196.

    Article  CAS  Google Scholar 

  15. Wu O, Robertson L, Twaddle S, et al. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Trhombosis: risk and economic assessment of thrmobophilia screening (TREATS) study. Health Technol Assess. 2006;10(11):1–110.

    Article  CAS  PubMed  Google Scholar 

  16. Kosmas IP, Tatsioni A, Ioannidis JP. Association of Leiden mutation in factor V gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens. 2003;21(7):1121–1128.

    Article  Google Scholar 

  17. Clark P, Walker ID, Govan L, Wu O, Greer IA. The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes. Br J Haematol. 2008;140(2):236–240.

    PubMed  Google Scholar 

  18. Silver RM, Zhao Y, Spong CY, et al. Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol. 2010;115(1):14–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Kupferminc MJ. Thrombophilia and pregnancy. Reprod Biol Edocrinol. 2003;14(1):111.

    Article  Google Scholar 

  20. Wells PS, Rodger MA. Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications. J Thromb Haemost. 2004;2(5):1188–1190.

    Article  Google Scholar 

  21. Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol. 2003;101(6):1333–1344.

    PubMed  Google Scholar 

  22. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol. 1992;166(5):1318–1323.

    Article  CAS  PubMed  Google Scholar 

  23. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.

    Article  CAS  PubMed  Google Scholar 

  24. Erkan D, Harrison MJ, Levy R, et al. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum. 2007;56(7):2382–23891.

    Article  CAS  PubMed  Google Scholar 

  25. Nelson SM, Greer IA. The potential role of heparin in assisted conception. Hum Reprod Update. 2008;14(6):623–645.

    Article  CAS  PubMed  Google Scholar 

  26. Brenner B, Hoffmann R, Blumenfeld Z, Weiner Z, Younis JS. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost. 2000;83(5):693–697.

    Article  CAS  PubMed  Google Scholar 

  27. Kupferminc MJ, Fait G, Many A, et al. Low molecular weight heparin for the prevention of obstetric complications in women with thrombophilias. Hypert Pregnancy. 2001;20(1):35–44.

    Article  CAS  Google Scholar 

  28. Carp H, Dolitzky M, Inbal A. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. J Thromb Haemost. 2002;1(3):433–438.

    Article  Google Scholar 

  29. Gris JC, Mares P. The long and winding road…towards LMWH for pregnancy loss. J Thromb Haemost. 2005;3(4):224–226.

    Article  CAS  PubMed  Google Scholar 

  30. Gris JC, Mercier E, Querè I, et al. Low-molecular weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood. 2004;103(10):3695–3699.

    Article  CAS  PubMed  Google Scholar 

  31. Grandone E, Brancaccio V, Colaizzo D, et al. Preventig adverse obstetric outcomes in women weith genetic thrombophilia. Fertil Steril. 2002;78(2):371–375.

    Article  PubMed  Google Scholar 

  32. Bar J, Mashiah R, Cohen-Sacher B, et al. Effect of thromboprophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications. Thromb Res. 2001;101(4):235–241.

    Article  CAS  PubMed  Google Scholar 

  33. Brenner B, Hoffmann R, Carp H, et al. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. J Thromb Haemost. 2005;3(2):227–229.

    Article  CAS  PubMed  Google Scholar 

  34. Lindqvist PG, Merlo J. Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence? Thromb Haemost. 2005;3(2):221–223.

    Article  CAS  Google Scholar 

  35. Altman DG. Better reporting of randomised controlled trials: the CONSORT statement. BMJ. 1996;313(7057):570–571.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Leduc L, Dubois E, Takser L, Rey E, David M. Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia. J Obstet Gynaecol Can. 2007;29(10):787–793.

    Article  PubMed  Google Scholar 

  37. Abou-Nassar K, Kovacs MJ, Kahn SR, et al. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial. Thromb Haemost. 2007;98(1):163–171.

    Article  CAS  PubMed  Google Scholar 

  38. Isermann B, Sood R, Pawlinski R, et al. Thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat Med. 2003;9(3):258–260.

    Article  CAS  Google Scholar 

  39. Girardi G, Redecha B, Salmon JE. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med. 2004;10(11):1222–1226.

    Article  CAS  PubMed  Google Scholar 

  40. Mousa HA, Alfirević Z. Thrombophilia and adverse pregnancy outcome. Croat Med J. 2001;42(2):135–145.

    CAS  PubMed  Google Scholar 

  41. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol. 2008;112(2 pt 1):359–372.

    Article  PubMed  Google Scholar 

  42. Greer IA, Nelson-Piercy C. Low-molecular weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005;106(2):401–407.

    Article  CAS  PubMed  Google Scholar 

  43. ACOG. Management of recurrent pregnancy loss. Practice Bull. 2001;24(2):1–12.

    Google Scholar 

  44. Dolitzky M, Inbal A, Segal Y, Weiss A, Brenner B, Carp H. A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriage. Fertil Steril. 2006;86(2):362–366.

    Article  PubMed  Google Scholar 

  45. Fawzy M, Shokeir T, El-Tatongy M, Warda O, El-Refaiey AA, Mosbah A. Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study. Arch Gynecol Obstet. 2008;278(1):33–38.

    Article  CAS  PubMed  Google Scholar 

  46. Kaandorp SP, Goddijn M, Van der Post JAM. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med. 2010;362(17):1586–1596.

    Article  CAS  PubMed  Google Scholar 

  47. Bose P, Black S, Kadyrov M, et al. Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. Am J Obstet Gynecol. 2005;192(1):23–30.

    Article  CAS  PubMed  Google Scholar 

  48. Di Simone N, Marana R, Castellani R, et al. Decreased expression of heparin-binding epidermal growth factor-like growth factor as a newly identified pathogenic mechanism of antiphospholipid-mediated defective placentation. Arthritis Rheum. 2010;62(5):1504–1512.

    Article  PubMed  CAS  Google Scholar 

  49. Girardi G. Heparin treatment in pregnancy loss: potential therapeutic benefits beyond anticoagulation. J Reprod Immunol. 2005;66(1):45–51.

    Article  CAS  PubMed  Google Scholar 

  50. Hochart H, Jenkins PV, Smith OP, White B. Low-molecular weight and unfractionated heparins induce a downregulation of inflammation: decreased levels of proinflammatory cytokines and nuclear factor-kappaB in LPS-stimulated human monocytes. Br J Haematol. 2006;133(1):62–67.

    Article  CAS  PubMed  Google Scholar 

  51. Salas A, Sans M, Soriano A, et al. Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism. Gut. 2000;47(1):88–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Schiessl B. Inflammatory response in preeclampsia. Mol Aspects Med. 2007;28(2):210–219.

    Article  CAS  PubMed  Google Scholar 

  53. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592–1594.

    Article  CAS  PubMed  Google Scholar 

  54. Mello G, Parretti E, Fatin C, et al. Low-molecular weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension. 2005;45(1):86–91.

    Article  CAS  PubMed  Google Scholar 

  55. Ferrazzani S, D’Alessio MC, Fatigante G. Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone. Hypertens Pregnancy. 2006;25(2):115–127.

    Article  CAS  Google Scholar 

  56. Leach RE, Romero R, Kim YM, et al. Pre-eclampsia and expression of heparin-binding EGF-like growth factor. Lancet. 2002;360(9341):1215–1219.

    Article  CAS  PubMed  Google Scholar 

  57. Leach RE, Kilburn BA, Petkova A, Romero R, Armant DR. Diminished survival of human cytotrophoblast cells exposed to hypoxia/reoxygenation injury and associated reduction of heparin-binding epidermal growth factor-like growth factor. Am J Obstet Gynecol. 2008;198(4):471.e1–e7.

    Article  CAS  Google Scholar 

  58. Rey E, Garneau P, David M, et al. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophila: a pilot randomized controlled trial. J Thromb Haemost. 2009;7(1):58–64.

    Article  CAS  PubMed  Google Scholar 

  59. Kher A, Bauersachs R, Nielsen JD. The management of thrombosis in pregnancy: role of low molecular weight heparin. Thromb Haemost. 2007;97(4):505–513.

    Article  CAS  PubMed  Google Scholar 

  60. Lekfou E, Khamashta M, Hampson G, Hunt BJ. Low molecular weight heparin induced osteoporosis and osteoporotic fractures: a myth or existing entity? Lupus. 2010;19(1):3–12.

    Article  Google Scholar 

  61. Janiaux E, Farquarson RG, Christinasen OB, Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 2006;21(9):2216–2222.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Catholic University of Sacred Heart, Policlinico “A.Gemelli”, Rome, Italy

    Silvia D’Ippolito MD, Manuela Veglia MD, Chiara Tersigni MD & Nicoletta Di Simone MD, PhD (Associate Professor)

  2. Unidad de Hemostasia y Trombosis, Servicio de Hematología, Hospital de La Santa Creu y Sant Pau, Barcelona, Spain

    Amparo Santamaria Ortiz MD

Authors
  1. Silvia D’Ippolito MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amparo Santamaria Ortiz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Manuela Veglia MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chiara Tersigni MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nicoletta Di Simone MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicoletta Di Simone MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

D’Ippolito, S., Ortiz, A.S., Veglia, M. et al. Low Molecular Weight Heparin in Obstetric Care: A Review of the Literature. Reprod. Sci. 18, 602–613 (2011). https://doi.org/10.1177/1933719111404612

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719111404612

Keywords

Search

Navigation